(2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg): clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg)

• Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
  NCT06511908 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve (2R,6R)-hydroxynorketamine (0.25 to 2.0 mg/kg)?

1 recruiting trial across 13 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.